Clinical studies recruiting near Louisville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity
Phase 2 · Monroe Biomedical Research · ERX Pharmaceuticals · NCT07570758 A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Norton Neuroscience Institute - Headache Clinic · AbbVie · NCT06602479 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10086, Louisville, Kentucky · Colorado Prevention Center · NCT06024746 LGG Supplementation in Patients With AUD and ALD
Phase 2 · University of Louisville Hospital · University of Louisville · NCT05178069 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · The James Graham Brown Cancer Center at University of Louisv · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Norton Children's Hospital · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Norton Children's Hospital · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Monroe Biomedical Research (former L-MARC Research Center) · Kallyope Inc. · NCT07674654 Spinal Cord Injury Registry - North American Clinical Trials Network
Phase N/A · University of Louisville Health Sciences Center · Robert G. Grossman, MD · NCT00178724 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Norton Hospital · Pfizer · NCT07073820 Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · University of Louisville · University of Cincinnati · NCT05911568 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · The James Graham Brown Cancer Center at University of Louisv · Alliance for Clinical Trials in Oncology · NCT07321652 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Norton Children's Hospital · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Norton Children's Hospital · Children's Oncology Group · NCT06368817 A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · University of Louisville · Fate Therapeutics · NCT06308978 Registry for Stage 2 Type 1 Diabetes
Phase N/A · Norton Brownsboro Hospital- Site Number : 8400030 · Sanofi · NCT06481904 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Norton Children's Hospital · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Norton Children's Research Institute/Affiliated with Univers · Giselle Sholler · NCT02559778 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Monroe Biomedical Research · Amgen · NCT07037433 IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
Phase N/A · University of Louisville · University of Louisville · NCT04208828 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Gastroenterology Health Partners · Eli Lilly and Company · NCT07415044 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · Norton Cancer Institute /ID# 260775 · AbbVie · NCT06109272 A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Site 1004 · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT07407933 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-
Phase 1 · Norton Cancer Institute · Regeneron Pharmaceuticals · NCT05685173 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Norton Children's Hospital · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Norton Cancer Institute Downtown · Pfizer · NCT07144280 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Gastroenterology Health Partners · Eli Lilly and Company · NCT06937086 Intermediate Visual Space Perception
NA · University of Louisville · University of Louisville · NCT05419713 Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Phase 1/Phase 2 · Norton Healthcare, Inc. · Heidelberg Pharma AG · NCT04879043 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · The University of Louisville, James Graham Brown Cancer Cent · Merck Sharp & Dohme LLC · NCT06077760

Look up another city

Look up another condition